Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$1.33B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$781M |
| 3 |
Tesla
TSLA
|
+$468M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$467M |
| 5 |
Home Depot
HD
|
+$344M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.36B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$860M |
| 3 |
Bank of America
BAC
|
+$413M |
| 4 |
Advanced Micro Devices
AMD
|
+$283M |
| 5 |
Salesforce
CRM
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 89.16% |
| 2 | Technology | 2.2% |
| 3 | Consumer Discretionary | 1.94% |
| 4 | Communication Services | 1.89% |
| 5 | Healthcare | 1.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1926
CALL
Kinsale Capital Group
KNSL
$8.66B
| $11.4M | ﹤0.01% |
112,200
+106,900
| +2,017% | +$10.6M |
|
1927
CALL
NovoCure
NVCR
$2.11B
| $11.4M | ﹤0.01% |
135,100
-73,800
| -35% | -$5.96M |
|
1928
PUT
Crown Holdings
CCK
$12.9B
| $11.4M | ﹤0.01% |
156,600
-11,500
| -7% | -$820K |
|
|
PLAN
1929
PUT
DELISTED
Anaplan, Inc.
PLAN
| $11.4M | ﹤0.01% |
216,800
-98,200
| -31% | -$4.87M |
|
1930
Carnival Corporation Ltd
CCL
$34.6B
| $11.4M | ﹤0.01% |
223,347
+18,040
| +9% | +$806K |
|
1931
Equity Lifestyle Properties
ELS
$12.5B
| $11.3M | ﹤0.01% |
161,066
+11,208
| +7% | +$779K |
|
|
TRTN
1932
CALL
DELISTED
Triton International Limited
TRTN
| $11.3M | ﹤0.01% |
281,600
-258,000
| -48% | -$9.55M |
|
1933
PUT
Editas Medicine
EDIT
$505M
| $11.3M | ﹤0.01% |
382,100
+43,200
| +13% | +$1.08M |
|
|
BLD
1934
PUT
DELISTED
TopBuild
BLD
| $11.3M | ﹤0.01% |
109,600
-43,300
| -28% | -$4.5M |
|
|
CONE
1935
CALL
DELISTED
CyrusOne Inc Common Stock
CONE
| $11.3M | ﹤0.01% |
172,600
+126,400
| +274% | +$8.68M |
|
1936
DXC Technology
DXC
$1.76B
| $11.3M | ﹤0.01% |
300,149
-284,825
| -49% | -$9.29M |
|
1937
Digital Realty Trust
DLR
$71.4B
| $11.3M | ﹤0.01% |
94,138
+85,481
| +987% | +$10.5M |
|
1938
Nektar Therapeutics
NKTR
$2.57B
| $11.3M | ﹤0.01% |
34,785
-15,557
| -31% | -$4.51M |
|
|
NVEE
1939
PUT
DELISTED
NV5 Global
NVEE
| $11.2M | ﹤0.01% |
891,200
+223,200
| +33% | +$3.25M |
|
1940
CALL
Vornado Realty Trust
VNO
$7.27B
| $11.2M | ﹤0.01% |
169,000
+8,900
| +6% | +$576K |
|
1941
PUT
Ares Capital
ARCC
$14.3B
| $11.2M | ﹤0.01% |
601,800
-375,900
| -38% | -$6.98M |
|
1942
CALL
Floor & Decor
FND
$5.71B
| $11.2M | ﹤0.01% |
220,600
+138,900
| +170% | +$6.51M |
|
1943
PUT
Markel Group
MKL
$22.5B
| $11.2M | ﹤0.01% |
9,800
+2,000
| +26% | +$2.28M |
|
1944
CALL
iShares MSCI Taiwan ETF
EWT
$11.8B
| $11.2M | ﹤0.01% |
272,100
+254,100
| +1,412% | +$10M |
|
|
DCPH
1945
PUT
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $11.2M | ﹤0.01% |
179,800
+27,300
| +18% | +$1.3M |
|
1946
CALL
LCI Industries
LCII
$2.51B
| $11.2M | ﹤0.01% |
104,400
+72,300
| +225% | +$7.32M |
|
1947
CALL
ProShares Ultra Silver
AGQ
$1.67B
| $11.2M | ﹤0.01% |
352,800
+66,900
| +23% | +$2.02M |
|
1948
CALL
Tractor Supply
TSCO
$18.1B
| $11.2M | ﹤0.01% |
597,500
-124,000
| -17% | -$2.35M |
|
1949
CALL
CRISPR Therapeutics
CRSP
$5.76B
| $11.2M | ﹤0.01% |
183,100
-15,800
| -8% | -$863K |
|
1950
Global X Silver Miners ETF NEW
SIL
$5.59B
| $11.1M | ﹤0.01% |
335,999
+62,828
| +23% | +$1.88M |
|
Similar funds
Jeff Yass's Q4 2019 Portfolio in Review
As of Q4 2019, Jeff Yass held 11,328 positions worth $347B, up 16% from $298B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Jeff Yass's Q4 2019 filing shows 1,232 new, 3,827 increased, 4,449 reduced and 1,709 closed positions. Its largest new stake was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M. The largest sale was Amazon, an estimated $1.36B.
By sector, the portfolio is most concentrated in Miscellaneous at 89% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2019 buy was Invesco Zacks Mid-Cap ETF: 1,353,476 shares worth $104M.
- Jeff Yass added most to Boeing in Q4 2019, an estimated $1.33B increase.
- Jeff Yass's biggest Q4 2019 reduction was Amazon, cutting an estimated $1.36B.
- Jeff Yass fully exited Celgene Corp in Q4 2019, selling an estimated $164M.
- Jeff Yass's ten largest holdings make up 26% of its $347B portfolio in Q4 2019.
- Jeff Yass opened 1,232 new positions and closed 1,709 in Q4 2019.
- Jeff Yass's portfolio value rose 16% quarter-over-quarter to $347B.
Based on Susquehanna International Group's 13F filing for Q4 2019, filed 14 Feb 2020.